Benchmarking biotech and pharmaceutical product development

被引：6

作者：

Drakeman, Donald L. ^{[1
,2
]}

机构：

[1] Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Cambridge, England

[2] Advent Venture Partners, London, England

来源：

NATURE BIOTECHNOLOGY | 2014年 / 32卷 / 07期

关键词：

D O I：

10.1038/nbt.2947

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The biotech sector's record in originating high-priority medicines exceeds that of the pharmaceutical industry, its costs are lower and its products have comparable revenues.

引用

页码：621 / 625

页数：5